Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
1992, Immunology Today
…
4 pages
1 file
occupied by its separate ligand does not affect proliferation. Therefore, this signal might drive B cells to an alternative differentiation pathway: the formation of memory B cells 12-14.
Proceedings of the National Academy of Sciences, 2001
Investigation of human genome sequences with a consensus sequence derived from receptors for the Fc region of Igs (FcR) led to the identification of a subfamily of five Ig superfamily members that we term the Fc receptor homologs (FcRHs). The closely linked FcRH genes are located in a chromosome 1q21 region in the midst of previously recognized FcR genes. This report focuses on the FcRH1, FcRH2, and FcRH3 members of this gene family. Their cDNAs encode type I transmembrane glycoproteins with 3-6 Ig-like extracellular domains and cytoplasmic domains containing consensus immunoreceptor tyrosine-based activating and͞or inhibitory signaling motifs. The five FcRH genes are structurally related, and their protein products share 28 -60% extracellular identity with each other. They also share 15-31% identity with their closest FcR relatives. The FcRH genes are expressed primarily, although not exclusively, by mature B lineage cells. Their conserved structural features, patterns of cellular expression, and the inhibitory and activating signaling potential of their transmembrane protein products suggest that the members of this FcRH multigene family may serve important regulatory roles in normal and neoplastic B cell development.
The Journal of Immunology, 2006
Immunology, 2014
B-cell antigen receptor (BCR) signalling and its regulation through negative and positive regulators are critical for balancing B-cell response and function. Human Fc receptor like-2 (FCRL2), a member of the newly identified FCRL family, could influence B-cell signalling due to possession of both immunoreceptor tyrosine-based activation and inhibitory motifs (ITAM and ITIM). Since the natural ligand of FCRL2 has not been identified, we generated FCRL2-specific monoclonal antibodies (mAbs) and employed them to investigate the influence of FCRL2 stimulation on BCR signalling in an FCRL2-expressing B-cell line. Two anti-FCRL2 mAb-producing hybridoma clones (5A7-E7 and 3D8-G8) were selected. None of the mAbs displayed any cross-reactivity with the other members of the FCRL family including recombinant FCRL1,-3,-4 and-5, as tested by FACS and ELISA techniques. Engagement of the FCRL2 by these mAbs resulted in significant inhibition of BCR signalling mediators such as calcium mobilization and phosphorylation of the mitogen-activated protein kinases Erk, p38 and Jnk. These findings indicate that the FCRL2 ITIM motifs are functional and the anti-FCRL2 mAbs may mimic the natural ligand of FCRL2 by induction of inhibitory signals in B cells.
Journal of Experimental Medicine, 2006
The inappropriate expansion and activation of autoreactive memory B cells and plasmablasts contributes to loss of self-tolerance in systemic lupus erythematosus (SLE). Defects in the inhibitory Fc receptor, Fc𝛄RIIB, have been shown to contribute to B cell activation and autoimmunity in several mouse models of SLE. In this paper, we demonstrate that expression of Fc𝛄RIIB is routinely up-regulated on memory B cells in the peripheral blood of healthy controls, whereas up-regulation of Fc𝛄RIIB is considerably decreased in memory B cells of SLE patients. This directly correlates with decreased Fc𝛄RIIB-mediated suppression of B cell receptor-induced calcium (Ca 2+ ) response in those B cells. We also found substantial overrepresentation of African-American patients among those who failed to up-regulate Fc𝛄RIIB. These results suggest that the inhibitory receptor, Fc𝛄RIIB, may be impaired at a critical checkpoint in SLE in the regulation of memory B cells; thus, Fc𝛄RIIB represents a novel target for therapeutic interventions in this disease.
Journal of …, 2009
FcγRIIB is an inhibitory receptor which plays a role in limiting B cell and DC activation. Since FcγRIIB is known to dampen the signaling strength of the BCR, we wished to determine the impact of FcγRIIB on the regulation of BCRs which differ in their affinity for DNA. For these studies, FcγRIIB deficient BALB/c mice were bred with mice expressing the transgene-encoded H chain of the R4A anti-DNA antibody which gives rise to BCRs which express high, low or no affinity for DNA. The deletion of FcγRIIB in R4A BALB/c mice led to an alteration in the B cell repertoire, allowing for the expansion and activation of high affinity DNA-reactive B cells. By 6 to 8 months of age, R4A × FcγRIIB-/- BALB/c mice spontaneously developed anti-DNA antibody titers. These mice also displayed an induction of IFN-inducible genes and an elevation in levels of the B cell survival factor, BAFF. These data demonstrate that FcγRIIB preferentially limits activation of high affinity autoreactive B cells and can influence the activation of DC through an immune complex-mediated mechanism.
The Journal of Immunology, 2000
Journal of Autoimmunity, 2009
FcγRIIB is an inhibitory receptor which plays a role in limiting B cell and DC activation. Since FcγRIIB is known to dampen the signaling strength of the BCR, we wished to determine the impact of FcγRIIB on the regulation of BCRs which differ in their affinity for DNA. For these studies, FcγRIIB deficient BALB/c mice were bred with mice expressing the transgene-encoded H chain of the R4A anti-DNA antibody which gives rise to BCRs which express high, low or no affinity for DNA. The deletion of FcγRIIB in R4A BALB/c mice led to an alteration in the B cell repertoire, allowing for the expansion and activation of high affinity DNA-reactive B cells. By 6 to 8 months of age, R4A × FcγRIIB -/-BALB/c mice spontaneously developed anti-DNA antibody titers. These mice also displayed an induction of IFN-inducible genes and an elevation in levels of the B cell survival factor, BAFF. These data demonstrate that FcγRIIB preferentially limits activation of high affinity autoreactive B cells and can influence the activation of DC through an immune complexmediated mechanism.
Journal of Leukocyte Biology, 2011
The biological roles of B cell membrane proteins in the FCRL family are enigmatic. FCRL proteins, including FCRL5, were shown to modulate early BCR signaling, although the subsequent, functional consequences of receptor engagement are poorly understood. We found that FCRL5 surface protein itself was induced temporarily upon BCR stimulation of human, naive B cells, indicating precise control over timing of FCRL5 engagement. Cross-linking of FCRL5 on cells induced to express FCRL5 enhanced B cell proliferation significantly. This enhancement required costimulation of the BCR and TLR9, two signals required for optimal proliferation of naive B cells, whereas T cell help in the form of anti-CD40 and IL-2 was dispensable. In addition, we found that FCRL5 stimulation generated a high proportion of cells displaying surface IgG and IgA. Optimal development of cells expressing switched isotypes required T cell help, in addition to stimuli found necessary for enhanced proliferation. Surprising...
Science Translational Medicine, 2013
Allele-dependent expression of activating FcγRIIc on human B cells enhances humoral immunity.
2002
In an attempt to repeat the FACS analyses of surface antigens that were described as diff erentially expressed between naive and memory B cells in our paper, we observed no or only minor diff erences for most of these molecules. A systematic reanalysis of the primary data in the laboratories of R. Küppers and M. Müschen revealed that incorrect FACS instrument compensations were responsible for the discrepancy (double stainings were performed, laboratory of M. Müschen).
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
The Journal of experimental medicine, 1990
Journal of Experimental Medicine, 2007
Journal of Clinical Investigation
Journal of Biological Chemistry, 1996
Journal of Biological Chemistry, 1996
Cellular Immunology
European Journal of Immunology, 1990
Nature Immunology, 2009
British Journal of Haematology, 2004
Cellular Immunology, 2012
The Journal of Immunology, 2007
Cellular Immunology, 1996
Proceedings of the National Academy of Sciences, 2011
Journal of Experimental Medicine, 1975
European Journal of Immunology, 2004
The Journal of Immunology, 2004